Navigation Links
Biotech 2004: Cautious optimism

CHICAGO Though spring is in the air and we are emerging into the second week of March, its still difficult to look in the crystal ball and say whether this will be a good or bad year for biotechnology. In the first two months of 2004, though, some significant activities have already taken place that impact the land of U.S. biotech. Witness these:

1. The
Full article >>> parture of a relatively new FDA commissioner, which leaves a gaping hole at this critical agency.

6. The opening of the biotech IPO market, which has raised $917 million since the fourth quarter of 2003. There are 13 more IPOs in registration with another 25 companies behind this group looking to go public.

Including the 12 companies that went public in the last part of 2003, t......

Full article >>> his was recently discussed by a panel of five investment bank analysts who specialize in the biotech, specialty Pharma and Big Pharma arenas. (Disclosure: columnist has a role at IBIO.)

The events emcee, Jim Hussey (the CEO of NeoPharm, one of Chicagolands leading biotech companies), led a vigorous discussion on the terrain for biotech......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 03/10/04


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Biotech executive books a career flight thats closer to home
3. Gala Biotech among companies sold for $3.3 billion
4. Biotech with Madison ties raises $21M in capital
5. Biotech firm uses live heart tissue in drug screens
6. Biotech talent drew venture-funded firm to Madison
7. Biotech firm has strokes, Alzheimers in its sights
8. 42 days until the 2006 Olympics of Biotechnology in Chicago
9. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
10. Biotech leads list of top U.S. companies to work for
11. Biotech flourishes in 2005 while Big Pharma is on the decline
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics ... biopharmaceutical products for companion animals, will host a live conference ... to discuss financial results from the fourth quarter and full ... and investors may access the audio webcast or ... ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... education provider of women’s health, primary care, and specialty education, announced today ... Medical Education (ACCME). ACCME’s Accreditation with Commendation is a six-year accreditation and ...
(Date:2/22/2017)... , Feb. 22, 2017 Origin (Origin Agritech, LLC, ... trait and seed provider, and Arcadia (Arcadia ... that develops and commercializes agricultural productivity traits and nutritional products, today ... corn biotechnology product developed in China to ... regulatory trials. ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
Breaking Biology Technology:
(Date:2/8/2017)... About Voice Recognition Biometrics Voice recognition biometrics ... a stored voiceprint template. Acoustic features of an ... are compared to distinguish between individual voices. Voice ... PCs already have a microphone and can authenticate ... are most likely to be deployed in telephone-based ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/8/2017)... 7, 2017 Report Highlights The ... from $8.3 billion in 2016 at a compound annual ... Report Includes - An overview of the global ... with data from 2015 and 2016, and projections of ... of the market on the basis of product type, ...
Breaking Biology News(10 mins):